INVO Bioscience (NASDAQ:INVO) Shares Down 4.5% – Here’s What Happened

INVO Bioscience, Inc. (NASDAQ:INVO) dropped 4.5% during mid-day trading on Monday . The stock traded as low as $0.81 and last traded at $0.81. Approximately 19,996 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.85.

INVO Bioscience Price Performance

The firm has a 50 day moving average price of $0.79 and a 200-day moving average price of $0.83.

Institutional Trading of INVO Bioscience

A hedge fund recently bought a new stake in INVO Bioscience stock. CWC Advisors LLC. bought a new stake in INVO Bioscience, Inc. (NASDAQ:INVO) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned about 2.64% of INVO Bioscience at the end of the most recent reporting period. Institutional investors own 12.02% of the company’s stock.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.